Inspirata

Caradigm is a provider of intelligent healthcare analytics and population health management solutions. The company specializes in enterprise population health management, visual analytics, and care management, along with a cloud-hosted intelligence platform. These services are designed to assist healthcare organizations in enhancing patient care, reducing costs, and effectively managing risk. By offering insights into patients, populations, and performance, Caradigm aims to empower healthcare entities to make informed decisions and improve overall health outcomes.

Omnyx, LLC is a joint venture between GE Healthcare and UPMC, located in Pittsburgh, PA, and Piscataway, NJ. The company specializes in digital pathology solutions designed to transition pathology departments to an all-digital workflow. Omnyx has developed the Omnyx IDP solution, which includes image acquisition devices, workflow software, and consulting services aimed at transforming cancer care. By closely collaborating with pathologists at UPMC and other institutions, Omnyx tailors its innovations to meet the needs of anatomic pathologists globally. Its products are designed for in vitro diagnostic use in specific clinical applications while being intended for research use in other areas. Omnyx's technology facilitates enhanced collaboration and streamlines case management, ultimately aiding medical organizations and cancer treatment centers in achieving effective cancer diagnoses and personalized patient care.

Artificial Intelligence in Medicine, Inc. is a software engineering firm based in Toronto, Canada, specializing in the development of information systems that utilize Artificial Intelligence (AI) and Natural Language Processing (NLP) to enhance healthcare outcomes. Founded in 1983, the company focuses on extracting cancer-related information from clinical documents, including pathology reports, molecular testing reports, treatment plans, and clinician notes. By designing, developing, and deploying advanced informatics solutions, Artificial Intelligence in Medicine aims to improve medical research, disease prevention, and the overall delivery of healthcare services, ultimately benefiting patients and aiding in cancer control. The company has operated as a subsidiary of Inspirata, Inc. since January 2018.

Precision Medicine Network, Inc. is a Massachusetts-based company established in 2011, focusing on enhancing the adoption of precision medicine through its innovative knowledge visualization and decision support platform. This platform, known as Crosswalk Insight: Oncology, is designed to facilitate the integration of precision medicine into clinical practice. The company serves a diverse array of professionals, including oncologists, pathologists, pharmaceutical companies, clinical trial developers, and healthcare executives, among others. By providing tools that connect providers, patients, and payers, Precision Medicine Network aims to address barriers in the healthcare landscape and unlock the potential of precision healthcare. The company's origins trace back to the Genomic Medicine Initiative at Harvard Medical School, reflecting its commitment to advancing cancer diagnosis and treatment through technology and informed decision-making.